North America Sleep Disorder Market Databank

North America Sleep Disorder Market Databank

The Sleep Disorder market was valued at $13,700.0 Million in 2020, and is projected to reach $24,896.6 Million by 2029 growing at a CAGR of 6.91% from 2021 to 2029. Sleep apnea segment is expected to be the highest contributor to this market, with $5,274.6 Million in 2020, and is anticipated to reach $9,604.4 Million by 2029, registering a CAGR of 6.93%. Narcolepsy segment is anticipated to reach $5,510.9 Million by 2029 with the highest CAGR of 7.02%. Sleep apnea and Narcolepsy segments collectively expected to account for about 60.4% share of the Sleep Disorder market in 2020, with the former constituting around 38.5% share. Narcolepsy and Sleep apnea segments are expected to witness significant growth rates at a CAGR of 7.02% and 6.93% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 60.4% in the overall Sleep Disorder market in 2020, and is anticipated to reach 60.7% by 2029.

The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.


1. GLOBAL SLEEP DISORDER MARKET, BY DISORDER TYPE
1.1. OVERVIEW
1.2. SLEEP APNEA
1.2.1 SLEEP APNEA MARKET, BY REGION
1.2.1.1 North America Sleep apnea Market, By Country
1.2.1.2 Europe Sleep apnea Market, By Country
1.2.1.3 Asia-Pacific Sleep apnea Market, By Country
1.2.1.4 Rest of World Sleep apnea Market, By Country
1.3. INSOMNIA
1.3.1 INSOMNIA MARKET, BY REGION
1.3.1.1 North America Insomnia Market, By Country
1.3.1.2 Europe Insomnia Market, By Country
1.3.1.3 Asia-Pacific Insomnia Market, By Country
1.3.1.4 Rest of World Insomnia Market, By Country
1.4. RESTLESS LEGS SYNDROME (RLS)
1.4.1 RESTLESS LEGS SYNDROME (RLS) MARKET, BY REGION
1.4.1.1 North America Restless legs syndrome (RLS) Market, By Country
1.4.1.2 Europe Restless legs syndrome (RLS) Market, By Country
1.4.1.3 Asia-Pacific Restless legs syndrome (RLS) Market, By Country
1.4.1.4 Rest of World Restless legs syndrome (RLS) Market, By Country
1.5. NARCOLEPSY
1.5.1 NARCOLEPSY MARKET, BY REGION
1.5.1.1 North America Narcolepsy Market, By Country
1.5.1.2 Europe Narcolepsy Market, By Country
1.5.1.3 Asia-Pacific Narcolepsy Market, By Country
1.5.1.4 Rest of World Narcolepsy Market, By Country
1.6. OTHER DISORDER TYPES
1.6.1 OTHER DISORDER TYPES MARKET, BY REGION
1.6.1.1 North America Other Disorder Types Market, By Country
1.6.1.2 Europe Other Disorder Types Market, By Country
1.6.1.3 Asia-Pacific Other Disorder Types Market, By Country
1.6.1.4 Rest of World Other Disorder Types Market, By Country
2. GLOBAL SLEEP DISORDER MARKET, BY PRODUCT
2.1. OVERVIEW
2.2.  DIAGNOSTICS
2.2.1  DIAGNOSTICS MARKET, BY REGION
2.2.1.1 North America  Diagnostics Market, By Country
2.2.1.2 Europe  Diagnostics Market, By Country
2.2.1.3 Asia-Pacific  Diagnostics Market, By Country
2.2.1.4 Rest of World  Diagnostics Market, By Country
2.3. THERAPEUTICS
2.3.1 THERAPEUTICS MARKET, BY REGION
2.3.1.1 North America Therapeutics Market, By Country
2.3.1.2 Europe Therapeutics Market, By Country
2.3.1.3 Asia-Pacific Therapeutics Market, By Country
2.3.1.4 Rest of World Therapeutics Market, By Country
3. GLOBAL SLEEP DISORDER MARKET, BY REGION
3.1. OVERVIEW
3.2. NORTH AMERICA
3.2.1 NORTH AMERICA SLEEP DISORDER MARKET, BY DISORDER TYPE
3.2.2 NORTH AMERICA SLEEP DISORDER MARKET, BY PRODUCT
3.2.3 NORTH AMERICA SLEEP DISORDER MARKET, BY COUNTRY
3.2.3.1 U.S.
3.2.3.1.1 U.S. Sleep Disorder Market, By Disorder Type
3.2.3.1.2 U.S. Sleep Disorder Market, By Product
3.2.3.2 Canada
3.2.3.2.1 Canada Sleep Disorder Market, By Disorder Type
3.2.3.2.2 Canada Sleep Disorder Market, By Product
3.2.3.3 Mexico
3.2.3.3.1 Mexico Sleep Disorder Market, By Disorder Type
3.2.3.3.2 Mexico Sleep Disorder Market, By Product
TABLE 1. GLOBAL SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
TABLE 2. SLEEP APNEA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 3. NORTH AMERICA SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 4. EUROPE SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 5. ASIA-PACIFIC SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 6. REST OF WORLD SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 7. INSOMNIA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 8. NORTH AMERICA INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 9. EUROPE INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 10. ASIA-PACIFIC INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 11. REST OF WORLD INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 12. RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 13. NORTH AMERICA RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 14. EUROPE RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 15. ASIA-PACIFIC RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 16. REST OF WORLD RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 17. NARCOLEPSY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 18. NORTH AMERICA NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 19. EUROPE NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 20. ASIA-PACIFIC NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 21. REST OF WORLD NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 22. OTHER DISORDER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 23. NORTH AMERICA OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 24. EUROPE OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 25. ASIA-PACIFIC OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 26. REST OF WORLD OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 27. GLOBAL SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 28.  DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 29. NORTH AMERICA  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 30. EUROPE  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 31. ASIA-PACIFIC  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 32. REST OF WORLD  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 33. THERAPEUTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 34. NORTH AMERICA THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 35. EUROPE THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 36. ASIA-PACIFIC THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 37. REST OF WORLD THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 38. GLOBAL SLEEP DISORDER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 39. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
TABLE 40. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 41. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 42. U.S. SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
TABLE 43. U.S. SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 44. CANADA SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
TABLE 45. CANADA SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 46. MEXICO SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
TABLE 47. MEXICO SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 48. ROW COUNTRIES SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 1. GLOBAL SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
FIGURE 2. SLEEP APNEA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 3. NORTH AMERICA SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 4. EUROPE SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 5. ASIA-PACIFIC SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 6. REST OF WORLD SLEEP APNEA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 7. INSOMNIA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 8. NORTH AMERICA INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 9. EUROPE INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 10. ASIA-PACIFIC INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 11. REST OF WORLD INSOMNIA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 12. RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 13. NORTH AMERICA RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 14. EUROPE RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 15. ASIA-PACIFIC RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 16. REST OF WORLD RESTLESS LEGS SYNDROME (RLS) MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 17. NARCOLEPSY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 18. NORTH AMERICA NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 19. EUROPE NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 20. ASIA-PACIFIC NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 21. REST OF WORLD NARCOLEPSY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 22. OTHER DISORDER TYPES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 23. NORTH AMERICA OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 24. EUROPE OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 25. ASIA-PACIFIC OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 26. REST OF WORLD OTHER DISORDER TYPES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 27. GLOBAL SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 28.  DIAGNOSTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 29. NORTH AMERICA  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 30. EUROPE  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 31. ASIA-PACIFIC  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 32. REST OF WORLD  DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 33. THERAPEUTICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 34. NORTH AMERICA THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 35. EUROPE THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 36. ASIA-PACIFIC THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 37. REST OF WORLD THERAPEUTICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 38. GLOBAL SLEEP DISORDER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 39. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
FIGURE 40. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 41. NORTH AMERICA SLEEP DISORDER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 42. U.S. SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
FIGURE 43. U.S. SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 44. CANADA SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
FIGURE 45. CANADA SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 46. MEXICO SLEEP DISORDER MARKET VALUE, BY DISORDER TYPE, 2020-2029, MILLION USD
FIGURE 47. MEXICO SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 48. ROW COUNTRIES SLEEP DISORDER MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings